Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia

NCT03280810 | Completed

• 1 other identifier: 1708158
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Beside these well-known symptoms (positive symptoms (such as delirium and delusions), negative symptoms (such as affective flattening and impoverishment of speech), disorganized behavior, patients with schizophrenia show different kinds of cognitive alterations and motor abnormalities. In schizophrenia, postural impairment could increase the attentional cost of daily motor tasks, leading to a lack of attentional resources, essential to achieve complex cognitive tasks. The intrication of cognitive and postural processings (both impaired in schizophrenia) can be explored by using of a dual-task paradigm.

Conditions

Schizophrenia

Keywords

Schizophrenia; Postural; Cognitive; task

Outcome Measures

Primary Outcomes (1)

• the losses of postural and attentional control

  To analyze the losses of postural and attentional control under dual-task condition. Losses of postural and attentional control are calculated by one composite score named mu (Baddeley, Della Sala, Papagno, \& Spinnler, 1997).

  At 8 weeks

Secondary Outcomes (2)

• cognitive decrement

  At 8 weeks

• postural decrement

  At 8 weeks

Study Arms (2)

Movement group

EXPERIMENTAL

patients with schizophrenia (experimental group) have psycho-corporal training once a week, during 1 hour and a half for a period of two months

Other: Movement group

Control group

NO INTERVENTION

No intervervention : patients with schizophrenia (comparator group) who don't have psycho-corporal training

Interventions

Movement group OTHER

Experimental group : patients with schizophrenia who realise psycho-corporal training once a week, during 1 hour and a half for a period of two months

Movement group

Eligibility Criteria

• Age: 18 Years - 55 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• a DSM-IV (Diagnostic and Statistical Manual of Mental Disorders) diagnosis of schizophrenia (men or women)
• Men or woman aged 18-55
• Patients with no change in antipsychotic medication and clinical status within four weeks prior to the study
• Affiliates or entitled to a social security scheme
• Have given their informed consent before participating in the study.

You may not qualify if:

• Intelligence Quotient below 70 (score PM38)
• History of head trauma, neurological disease or not stabilized serious physical illness
• Disorders related to the use of a psychoactive substance, as defined by the DSM-IV (abuse, dependence or withdrawal) within 6 months.

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Saint Etienne: lead

Study Sites (1)

Chu Saint-Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Study Officials

• Catherine MASSOUBRE, PhD

  CHU SAINT-ETIENNE

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: BASIC SCIENCE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 11, 2017
• First Posted: September 13, 2017
• Study Start: December 1, 2013
• Primary Completion: December 1, 2015
• Study Completion: December 1, 2015
• Last Updated: September 14, 2017

Record last verified: 2017-09

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)